VistaGen Therapeutics, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by VistaGen Therapeutics, Inc. on August 24, 2015. The report details the successful completion of a consent solicitation to amend the Company's Articles of Incorporation and its 2008 Stock Incentive Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance actions and does not contain financial performance data.
Material Changes
- Authorized Share Increase: The Company increased its authorized common stock from 10.0 million shares to 30.0 million shares.
- Stock Incentive Plan Expansion: The number of shares authorized for issuance under the 2008 Stock Incentive Plan was increased from 250,000 shares to 1.0 million shares.
- Corporate Action Completion: The consent solicitation was terminated on August 24, 2015, after receiving approval from holders of 893,830 shares, representing 99.96% of consents received and a majority of outstanding shares as of the July 16, 2015 record date.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, or contingencies beyond the successful execution of the shareholder vote. The Board of Directors elected to terminate the solicitation process immediately upon achieving the required majority.
Key Facts for Investor Verification
- Verify the effective date of the Certificate of Amendment filed with the Nevada Secretary of State on August 24, 2015.
- Confirm the updated total authorized share count of 30.0 million shares in subsequent filings.
- Review the amended 2008 Stock Incentive Plan to understand the new 1.0 million share issuance limit.
- Check the record date of July 16, 2015, to confirm the share count basis for the voting majority.